FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research gives a Sell rating

In his latest research note, analyst Christian Ehmann confirms his negative recommendation. The broker Warburg Research is keeping its Sell rating. The target price is reduced from EUR 24 to EUR 22.